Literature DB >> 2894801

The role of HTLV-I in tropical spastic paraparesis in Jamaica.

P Rodgers-Johnson1, O S Morgan, C Mora, P Sarin, M Ceroni, P Piccardo, R M Garruto, C J Gibbs, D C Gajdusek.   

Abstract

We report clinical and laboratory investigations of 47 native-born Jamaican patients with endemic tropical spastic paraparesis and of 1 patient with tropical ataxic neuropathy. Mean age at onset was 40 years, with a female-male preponderance (2.7:1). Neurological features of endemic tropical spastic paraparesis are predominantly those of a spastic paraparesis with variable degrees of proprioceptive and/or superficial sensory impairment. Using enzyme-linked immunoabsorbent assay (ELISA), IgG antibodies to human T-lymphotropic virus type I (HTLV-I) were present in 82% of sera and 77% of cerebrospinal fluids. On Western blot analysis, IgG antibodies detected the p19 and p24 gag-encoded core proteins in both serum and cerebrospinal fluid. Titers were tenfold higher by ELISA in serum than in cerebrospinal fluid, and some oligoclonal bands present in fluid were not seen in serum. Serum-cerebrospinal fluid albumin ratios were normal, and IgG indexes indicated intrathecal IgG synthesis. Histopathological changes showed a chronic inflammatory reaction with mononuclear cell infiltration, perivascular cuffing, and demyelination that was predominant in the lateral columns. In 1 patient, a retrovirus morphologically similar to HTLV-I on electron microscopy was isolated from spinal fluid. Our investigations show that endemic tropical spastic paraparesis in Jamaica is a retrovirus-associated myelopathy and that HTLV-I or an antigenically similar retrovirus is the causal agent.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2894801     DOI: 10.1002/ana.410230729

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  5 in total

1.  Comparison of a human T-cell lymphotropic virus type I strain from cerebrospinal fluid of a Jamaican patient with tropical spastic paraparesis with a prototype human T-cell lymphotropic virus type I.

Authors:  P S Sarin; P Rodgers-Johnson; D K Sun; A H Thornton; O S Morgan; W N Gibbs; C Mora; G McKhann; D C Gajdusek; C J Gibbs
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

2.  Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study.

Authors:  Ariella L G Coler-Reilly; Tomoo Sato; Toshio Matsuzaki; Masanori Nakagawa; Masaaki Niino; Masahiro Nagai; Tatsufumi Nakamura; Norihiro Takenouchi; Natsumi Araya; Naoko Yagishita; Eisuke Inoue; Yoshihisa Yamano
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 3.  Tropical spastic paraparesis/HTLV-I associated myelopathy. Etiology and clinical spectrum.

Authors:  P E Rodgers-Johnson
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

4.  Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells.

Authors:  T J Lehky; E P Cowan; L A Lampson; S Jacobson
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

5.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.